Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome.
Pharmaceutical Approval Update.
Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study.
How long is the presymptomatic phase of multiple sclerosis?
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.
Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35-55 epitope implicated in multiple sclerosis.
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Assessment of vitamin D status - a changing landscape.
Role of tumor necrosis factor-alpha in zebrafish retinal neurogenesis and myelination.
Web-based interventions in multiple sclerosis: the potential of tele-rehabilitation.
Gut microflora and multiple sclerosis.
Recent updates on molecular genetic engineering approaches and applications of human therapeutic proteins.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.
Which gait parameter can be used to evaluate gait improvement in multiple sclerosis?
LRP1 expression in microglia is protective during CNS autoimmunity.
The Myelinogenesis Process in Undernourished Rats Rehabilitated with Different Dietary Lipids.
Successive pregnancies in multiple sclerosis.
Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery.
Pages
« first
‹ previous
…
824
825
826
827
828
829
830
831
832
…
next ›
last »